BIX02189 Suppresses Adipogenesis and Lipid Accumulation Through Inhibition of MEK5-STAT3/STAT5 Signaling and Activation of AMPK in Adipocytes and Zebrafish
Open Access
- 21 July 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (14) , 6468
Abstract
Obesity is a major metabolic disorder characterized by excessive lipid accumulation and adipocyte differentiation. The mitogen-activated protein kinase kinase 5 (MEK5) signaling pathway has been implicated in diverse cellular processes; however, its role in adipogenesis remains incompletely understood. In this study, we investigated the anti-adipogenic effects of BIX02189, a selective MEK5 inhibitor, using 3T3-L1 adipocytes, human adipose-derived stem cells (hASCs), and zebrafish models. Treatment with BIX02189 significantly reduced lipid accumulation and triglyceride content during adipocyte differentiation in a dose-dependent manner without marked cytotoxicity. BIX02189 effectively suppressed MEK5 phosphorylation and downregulated the expression of key adipogenic transcription factors, including peroxisome proliferator-activated receptor gamma (PPAR-γ) and CCAAT/enhancer-binding protein alpha (C/EBP-α). In addition, BIX02189 decreased the phosphorylation of signal transducer and activator of transcription 3 (STAT3) and STAT5, as well as the expression of lipogenic markers such as fatty acid synthase (FAS), perilipin A, and leptin. Conversely, BIX02189 enhanced AMP-activated protein kinase (AMPK) phosphorylation and markedly reduced the protein and mRNA expression of acetyl-CoA carboxylase (ACC), a key enzyme involved in fatty acid synthesis. Similar anti-adipogenic effects were observed in hASCs. Furthermore, BIX02189 significantly attenuated lipid accumulation in a zebrafish obesity model without affecting body length or causing overt toxicity. Collectively, these findings demonstrate that pharmacological inhibition of MEK5 suppresses adipogenesis and lipid accumulation through regulation of the STAT3/STAT5–PPAR-γ axis and activation of AMPK signaling. These findings provide the first evidence that MEK5 inhibition exerts anti-adipogenic effects in adipocytes and zebrafish, highlighting the MEK5 signaling pathway as a previously unrecognized regulator of adipogenesis and lipid metabolism.Keywords
Funding Information
- Bisa Research Grant of Keimyung University (20230361)
This publication has 48 references indexed in Scilit:
- Oncogenic signaling of MEK5-ERK5Cancer Letters, 2017
- Regulation of AMP-activated protein kinase by natural and synthetic activatorsActa Pharmaceutica Sinica B, 2016
- AMPK: positive and negative regulation, and its role in whole-body energy homeostasisCurrent Opinion in Cell Biology, 2015
- The role of JAK–STAT signaling in adipose tissue functionBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014
- What We Talk About When We Talk About FatCell, 2014
- ERK5: Structure, regulation and functionCellular Signalling, 2012
- JAK2/STAT3 pathway is involved in the early stage of adipogenesis through regulating C/EBPβ transcriptionJournal of Cellular Biochemistry, 2010
- Fatty acid synthase gene expression in human adipose tissue: association with obesity and type 2 diabetesDiabetologia, 2007
- Transcriptional control of adipocyte formationCell Metabolism, 2006
- Regulation of cellular functions by the ERK5 signalling pathwayCellular Signalling, 2006